Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX)
CUSIP: M40527109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary shares, par value NIS 0.0000769 per share
- Shares outstanding
- 45,504,462
- Total 13F shares
- 10,211,002
- Share change
- -11,256
- Total reported value
- $19,401,301
- Price per share
- $1.90
- Number of holders
- 19
- Value change
- +$12,863
- Number of buys
- 9
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP M40527109?
CUSIP M40527109 identifies ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M40527109:
Top shareholders of ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Knoll Capital Management, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
13%
|
5,881,879
|
$9,999,194 | — | 31 Mar 2025 | |
| OPKO HEALTH, INC. |
13D/G
|
— |
8.1%
|
3,685,226
|
$8,660,281 | $0 | 16 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
5.9%
|
2,697,236
|
$4,585,301 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.3%
|
599,156
|
$1,018,565 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.97%
|
439,632
|
$747,374 | — | 31 Mar 2025 | |
| Phillip Schwartz |
3/4/5
|
President of R&D, Director |
—
class O/S missing
|
607,410
|
$601,336 | — | 20 Jan 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
198,831
|
$338,013 | — | 31 Mar 2025 | |
| Perigon Wealth Management, LLC |
13F
|
Company |
0.32%
|
145,843
|
$247,933 | — | 31 Mar 2025 | |
| Hillel Galitzer |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
190,573
mixed-class rows
|
$153,974 | — | 28 Apr 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
63,300
|
$107,610 | — | 31 Mar 2025 | |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC |
13F
|
Company |
0.1%
|
47,328
|
$80,458 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
34,766
|
$59,102 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
30,987
|
$52,678 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
21,136
|
$35,931 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.04%
|
18,140
|
$30,838 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.03%
|
12,554
|
$21,342 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
10,859
|
$18,460 | — | 31 Mar 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
10,000
|
$17,000 | — | 31 Mar 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.02%
|
9,000
|
$15,300 | — | 31 Mar 2025 | |
| Ramesh Ratan |
3/4/5
|
U.S.based CFO |
—
class O/S missing
|
10,000
|
$9,900 | — | 19 Jan 2022 | |
| Spiros Jamas |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
10,000
|
$9,900 | — | 18 Jan 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
1,560
|
$2,652 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
51
|
$87 | — | 31 Mar 2025 | |
| Roger Garceau |
3/4/5
|
Director |
—
class O/S missing
|
108,333
|
— | — | 01 Jan 2024 | |
| Ron Mayron |
3/4/5
|
Director |
—
class O/S missing
|
108,333
|
— | — | 01 Jan 2024 | |
| Arthur C. Santora II |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
35,000
|
— | — | 24 Apr 2023 |
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q2 2025
As of 30 Jun 2025,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,211,002 shares.
The largest 10 holders included
Knoll Capital Management, LLC, Point72 Asset Management, L.P., Schonfeld Strategic Advisors LLC, Parkman Healthcare Partners LLC, NORTHERN TRUST CORP, BESSEMER GROUP INC, HighTower Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and SIGNATURE ESTATE & INVESTMENT ADVISORS LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
18
Q2 2025 holders
19
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.